[1]赵 耀,张 芹,曹城玮,等.肥厚型梗阻性心肌病患者室间隔乙醇消融与心肌切除术后心电图变化[J].介入放射学杂志,2022,31(07):660-663.
　ZHAO Yao,ZHANG Qin,CAO Chengwei,et al.Electrocardiogram changes after ethanol ablation of interventricular septum and after myocardial resection in patients with hypertrophic obstructive cardiomyopathy： a comparative study[J].journal interventional radiology,2022,31(07):660-663.

点击复制

肥厚型梗阻性心肌病患者室间隔乙醇消融与心肌切除术后心电图变化()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Nishimura RA， Holmes DJ. Clinical practice. Hypertrophic obstructive cardiomyopathy［J］. N Engl J Med， 2004， 350： 1320- 1327.
［2］ Authors/Task Force members， Elliott PM， Anastasakis A， et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy： the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology（ESC）［J］. Eur Heart J， 2014， 35： 2733- 2779.
［3］ Maron BJ. Clinical course and management of hypertrophic cardiomyopathy［J］. N Engl J Med， 2018， 379： 655- 668.
［4］ 熊 峰． 梗阻性肥厚型心肌病治疗方法的现状与进展［J］． 心血管病学进展， 2019， 40：889- 893．
［5］ 阚 通，郭 俊，陈 亮，等． 经皮室间隔心肌化学消融术治疗老年梗阻性肥厚型心肌病临床疗效及安全性［J］． 介入放射学杂志， 2015， 24：946- 949．
［6］ 张 明，李占全，金元哲，等. 经皮经腔间隔心肌化学消融术治疗肥厚性梗阻型心肌病术后长期疗效观察［J］. 介入放射学杂志， 2004， 13：161- 165.
［7］ Lakkis NM， Nagueh SF， Dunn JK， et al. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy： one- year follow- up［J］. J Am Coll Cardiol， 2000， 36： 852- 855.
［8］ Chang SM， Nagueh SF， Spencer WH 3rd， et al. Complete heart block： determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy［J］. J Am Coll Cardiol， 2003， 42： 296- 300.
［9］ Talreja DR， Nishimura RA， Edwards WD， et al. Alcohol septal ablation versus surgical septal myectomy： comparison of effects on atrioventricular conduction tissue［J］. J Am Coll Cardiol， 2004， 44： 2329- 2332.
［10］ Kern MJ， Holmes DG， Simpson C， et al. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy［J］. Catheter Cardiovasc Interv， 2002， 56： 503- 507.
［11］ Wang S， Luo M， Sun H， et al. A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China［J］. Eur J Cardiothorac Surg， 2013， 43： 534- 540.
［12］ Qin JX， Shiota T， Lever HM， et al. Conduction system abnorma-lities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions［J］. Am J Cardiol， 2004， 93： 171- 175.
［13］ Kwon DH， Smedira NG， Thamilarasan M， et al. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation［J］. J Thorac Cardiovasc Surg， 2010， 140： 317- 324.
［14］ Lai Y， Guo H， Li J， et al. Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy［J］. Medicine（Baltimore）， 2017， 96： e9371.
［15］ Cui H， Schaff HV， Nishimura RA， et al. Conduction abnormalities and long- term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy［J］. J Am Coll Cardiol， 2019， 74： 645- 655.
［16］ Coakley E， Steinberg DH， Tibrewala A， et al. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern［J］. Am J Cardiol， 2008， 102： 621- 624.
［17］ Yang Q， Zhu C， Cui H， et al. Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation［J］. J Thorac Dis， 2021， 13： 1055- 1065.
［18］ Nguyen A， Schaff HV， Hang D， et al. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy： a propensity score- matched cohort［J］. J Thorac Cardiovasc Surg， 2019， 157： 306.e3- 315.e3.
［19］ 郑顺文，施鸿毓，戴锦杰，等． 梗阻性肥厚型心肌病患者经皮室间隔化学消融术后的长期生存情况［J］．中华心血管病杂志，2020， 48：294- 301．
［20］ Echahidi N， Pibarot P， O’hara G， et al. Mechanisms， prevention， and treatment of atrial fibrillation after cardiac surgery［J］. J Am Coll Cardiol， 2008， 51： 793- 801.
［21］ Guo Y， Wu X， Zheng X， et al. Usefulness of preoperative transforming growth factor- beta to predict new onset atrial fibrillation after surgical ventricular septal myectomy in patients with obstructive hypertrophic cardiomyopathy［J］. Am J Cardiol， 2017， 120： 118- 123.
［22］ Zhu C， Yang Q， Wang S， et al. Preoperative statin use is associated with less postoperative atrial fibrillation after myectomy in patients with hypertrophic obstructive cardiomyopathy［J］. Semin Thorac Cardiovasc Surg， 2021， 33： 713- 719.
［23］ Wei Z， Zhu E， Ren C， et al. Triglyceride- glucose index indepen-dently predicts new- onset atrial fibrillation after septal myectomy for hypertrophic obstructive cardiomyopathy beyond the traditional risk factors［J］. Front Cardiovasc Med， 2021， 8： 692511.
［24］ Moss TJ， Zipse MM， Krantz MJ， et al. Incidence of atrial fibrillation following alcohol septal ablation for hypertrophic cardiomyopathy［J］. Ann Noninvasive Electrocardiol， 2016， 21： 443- 449.
［25］ Strauss DG，Schocken DD. Marriott’s Practical Eletrocardiolography［M］. Philadelphia: Linppincott Williams Wilkins， 2021： 201.